Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India
· Delayed Price · Currency is INR 1,807.40
+8.00 (0.44%)
At close: Mar 9, 2026
NSE:SUNPHARMA Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,336,558 | 4,162,126 | 3,888,242 | 2,358,729 | 2,194,737 | 1,434,322 | Upgrade
|
| Market Cap Growth | 3.50% | 7.04% | 64.84% | 7.47% | 53.02% | 69.69% | Upgrade
|
| Enterprise Value | 4,112,973 | 3,989,271 | 3,792,904 | 2,296,495 | 2,136,376 | 1,424,670 | Upgrade
|
| Last Close Price | 1807.40 | 1717.85 | 1590.15 | 955.81 | 879.84 | 568.99 | Upgrade
|
| PE Ratio | 39.76 | 38.08 | 40.60 | 27.84 | 67.06 | 49.39 | Upgrade
|
| Forward PE | 35.50 | 35.80 | 42.36 | 28.97 | 28.54 | 26.49 | Upgrade
|
| PS Ratio | 7.63 | 7.92 | 8.02 | 5.38 | 5.68 | 4.28 | Upgrade
|
| PB Ratio | 5.55 | 5.74 | 5.79 | 3.98 | 4.30 | 2.90 | Upgrade
|
| P/TBV Ratio | 7.91 | 7.67 | 8.39 | 6.16 | 6.23 | 4.16 | Upgrade
|
| P/FCF Ratio | - | 34.85 | 39.14 | 82.08 | 29.30 | 28.69 | Upgrade
|
| P/OCF Ratio | - | 29.58 | 32.04 | 47.56 | 24.43 | 23.25 | Upgrade
|
| PEG Ratio | 2.74 | 2.39 | 2.97 | 1.99 | 1.46 | 1.31 | Upgrade
|
| EV/Sales Ratio | 7.24 | 7.59 | 7.82 | 5.23 | 5.53 | 4.25 | Upgrade
|
| EV/EBITDA Ratio | 25.51 | 26.65 | 29.46 | 19.71 | 21.04 | 17.07 | Upgrade
|
| EV/EBIT Ratio | 30.22 | 31.65 | 36.05 | 24.68 | 26.19 | 22.17 | Upgrade
|
| EV/FCF Ratio | - | 33.40 | 38.18 | 79.91 | 28.53 | 28.49 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.03 | 0.05 | 0.12 | 0.03 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.32 | 0.16 | 0.25 | 0.58 | 0.13 | 0.46 | Upgrade
|
| Debt / FCF Ratio | - | 0.20 | 0.33 | 2.40 | 0.17 | 0.77 | Upgrade
|
| Net Debt / Equity Ratio | -0.29 | -0.33 | -0.24 | -0.14 | -0.22 | -0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.41 | -1.59 | -1.23 | -0.71 | -1.12 | -0.68 | Upgrade
|
| Net Debt / FCF Ratio | - | -1.99 | -1.59 | -2.87 | -1.52 | -1.14 | Upgrade
|
| Asset Turnover | - | 0.59 | 0.58 | 0.58 | 0.56 | 0.49 | Upgrade
|
| Inventory Turnover | - | 1.10 | 1.08 | 1.12 | 1.17 | 1.05 | Upgrade
|
| Quick Ratio | - | 2.17 | 1.82 | 1.36 | 1.37 | 1.20 | Upgrade
|
| Current Ratio | - | 2.89 | 2.56 | 2.00 | 2.03 | 1.89 | Upgrade
|
| Return on Equity (ROE) | - | 15.71% | 15.20% | 15.43% | 6.74% | 4.61% | Upgrade
|
| Return on Assets (ROA) | - | 8.87% | 7.91% | 7.73% | 7.42% | 5.91% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.26% | 20.12% | 17.87% | 18.65% | 14.83% | 11.61% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 17.10% | 15.40% | 15.30% | 15.50% | 12.50% | Upgrade
|
| Earnings Yield | 2.52% | 2.63% | 2.46% | 3.59% | 1.49% | 2.02% | Upgrade
|
| FCF Yield | - | 2.87% | 2.56% | 1.22% | 3.41% | 3.49% | Upgrade
|
| Dividend Yield | 0.89% | 0.93% | 0.85% | 1.20% | 1.14% | 1.32% | Upgrade
|
| Payout Ratio | - | 33.07% | 30.26% | 29.73% | 65.97% | 53.70% | Upgrade
|
| Buyback Yield / Dilution | -0.24% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 0.65% | 0.93% | 0.85% | 1.20% | 1.14% | 1.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.